Home | History | Scientific Papers | Articles | Media
Books | FAQ | Viewpoints | Related Sites | Subject Index | Contact Us
    Subject Index > Bibliography > Peter Duesberg


Part 2- References
(Part 1)

Retroviruses as Carcinogens and Pathogens: Expectations and Reality

Peter H. Duesberg
Perspectives in Cancer Research

[Cancer Research 47, 1199-1220, March 1, 1987]
Department of Molecular Biology and Virus Laboratory,
University of California, Berkeley, California 94720

Second Part of Paper


I am grateful to R. Cardiff (Davis, CA), K. Cichutek, M. Gardner (Davis, CA), D. Goodrich, E. Humphries (Dallas, TX), J.A. Levy (San Francisco, CA), F. Lilly (New York, NY), G. S. Martin, G. Matioli (Los Angeles, CA), E. Noah (Villingen, Germany), S. Pfaff, W. Phares, D. Purtilo (Omaha, NE), H. Rubin, B. Singer, G. Stent, and R.-P. Zhou for critical comments or review of this manuscript or both and R.C. Gallo (NIH Bethesda, MD) for discussions.

For Table 1 and Figure 1 see printed publication.

* The abbreviations used are: RSV, Rous sarcoma virus; AIDS, acquired immunodeficiency syndrome; HTLV-1, human T-cell leukemia virus; MMTV, mouse mammary tumor virus; ATLV, adult T-cell leukemia virus; STLV-III, simian T-cell leukemia virus; ATL, adult T-cell leukemia; MCF, mink cell focus-forming; HIV, human immunodeficiency virus; ARV, AIDS-associated retrovirus.

** Koch's postulates define the steps required to establish a microorganism as the cause of a disease: (a) it must be found in all cases of the disease; (b) it must be isolated from the host and grown in pure culture; © it must reproduce the original disease when introduced into a susceptible host; and (d) it must be found present in the experimental host so infected.

Received 6/2/86; revised 10/14/86; accepted 11/11/86.

(This work was) supported by (OIG) National Cancer Institute Grant CA-39915A-01 and Council for Tobacco Research Grant 1547 and by a scholarship in residence of the Fogarty International Center, NIH, Bethesda, MD.

[Exponential power is not printed here, so the phrase "10 (3rd power)" indicates "1,000"]


1. Boveri, T. Zur Frage der Entstehung maligner Tumoren. Jena, Germany: Gustav Fischer Verlag, 1914.

2. Foulds, L. Neoplastic Development, Vols. 1 and 2. New York: Academic Press, 1969.

3. Burnett, M.F. The biology of cancer. In: H. German (ed.), Chromosomes and Cancer, Vol. 1, p. 21. New York: John Wiley & Sons, Inc., 1974.

4. Nowell, P.C. The clonal evolution of tumor cell populations. Science (Wash. DC), 194: 23-28, 1976.

5. Duesberg, P.H. Activated proto-onc genes: sufficient or necessary for cancer? Science (Wash.DC), 228: 669-677.

6. Rous, P. The challenge to man of the neoplastic cell. Science (Wash. DC), 157: 24-28, 1967.

7. Stanley, W.M. Virus-induced neoplasia-outlook for the future. Cancer Res., 20: 669-830, 1960.

8. Huebner, R.J., and Todaro, G. Oncogenes of RNA tumors viruses as determinants of cancer. Proc. Natl. Acad. Sci. USA, 64: 1087-1094, 1969.

9. Gross, L. Oncogenic Viruses. Elmsford, NY: Pergamon Press, 1970.

10. Kaplan, H.S. On the natural history of the murine leukemias: Presidential Address. Cancer Res., 27: 1325-1340, 1967.

11. Lwoff, A. Introduction-RNA viruses and host genome in oncogenesis, pp. 1-11. In: P. Emmelot and P. Bentvelzen (eds.), RNA Viruses and Host Genome in Oncogenesis, New York: American Elsevier Co., 1972.

12. Rowe, W.P. Genetic factors in the natural history of murine leukemia virus infection. Cancer Res., 33: 3061-3068, 1973.

13. Weiss, R., Teich, N., Varmus, H., and Coffin, J. RNA Tumor Viruses. Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1985.

14. Tooze, J. The Molecular Biology of Tumor Viruses. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1973.

15. Fenner, F., McAuslan, B.R., Mims, C.A., Sambrook, J., and White, D.O. The Biology of Animal Viruses. New York: Academic Press, 1974.

16. Weiss, R., Teich, N., Varmus, H., and Coffin, J. RNA Tumor Viruses. Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1982.

17. Levy, J.A. Xenotropic type C viruses. Curr. Top. Microbiol. Immunol., 79: 111-123, 1978.

18. Kozak, C., and Silver, J. The transmission and activation of endogenous mouse retroviral genomes. TIG Rev., 1: 331-334, 1985.

19. Duesberg, P.H. Retroviral Transforming genes in normal cells? Nature (Lond.), 304: 219-225, 1983.

20. Duesberg, P.H. Transforming genes of retroviruses. Cold Spring Harbor Symp. Quant. Biol., 44: 13-29, 1980.

21. Duesberg, P.H., and Vogt, P.K. Differences between the ribonucleic acid of transforming and nontransforming avian tumor viruses. Proc. Natl. Acad. Sci. USA, 67: 1673-1680, 1970.

22. Duesberg, P.H., Vogt, P.K., Beemon, K., and Lai, M. Avian RNA tumor viruses: mechanism of recombination and complexity of the genome. Cold Spring Harbor Symp. Quant. Biol., 39: 847-857, 1974.

23. Wang, L.H., Duesberg, P.H., Beemon, K., and Vogt, P.K. Mapping RNase T-1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end. J. Virol., 16: 1051-1070, 1975.

24. Wang, L.H., Galehouse, D., Mellon, P., Duesberg, P., Mason, W.S., and Vogt, P.K. Mapping oligonucleotides of Rous sarcoma virus RNA that segregate with polymerase and group-specific antigen markers in recombinants. Proc. Natl. Acad. Sci. USA, 73: 3952-3956, 1976.

25. Rubin, H., and Temlin, H.M. A radiological study of cell-virus interaction in the Rous sarcoma. Virology, 7: 75-91, 1958.

26. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Danguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rosenbaum, W., and Montagnier, L. Isolation of T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (Wash. DC), 220: 868-870, 1983.

27. Wong-Staal, F., and Gallo, R.C. Human T-lymphotropic retroviruses. Nature (Lond.), 317: 395-403, 1985.

28. Sodroski, J., Goh, W.C., Rosen, C., Dayton, H., Terwilliger, E., and Haseltine, W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (Lond.), 321: 412-417, 1986.

29. Ellermann, V., and Bang, O. Experimentelle leukaemie bei Huehnern. Centralblatt Bakteriol. Parasitenk. Abt. I Orig., 46: 595-609, 1908.

30. Burmester, B.R., Gentry, R.F., and Waters, N.F. The presence of the virus of visceral lymphomatosis in embrionated eggs of normal appearing hens. Science (Wash. DC), 34: 609-617, 1955.

31. Rubin, H., Fanshier, L., Cornelius, A., and Hughes, W.F. Tolerance and immunity in chickens after congenital and contact infection with avian leukosis virus. Virology, 17: 143-156, 1962.

32. Purchase, H.G., and Burmester, B.R. Leukosis sarcoma group. In: M.S. Hofstad et al. (eds.), Diseases of Poultry, Ed. 6, pp. 502-568. Ames, IA: The Iowa State University Press, 1972.

33. Calnek, B.W. Neoplastic diseases. Introduction. In: M.S. Hofstad et al. (eds.), Diseases of Poultry, Ed. 6, pp. 467-470. Ames, IA: The Iowa State University Press, 1972.

34. Calnek, B.W., and Witter, R.L. Marek's disease. In: M.S. Hofstad et al. (eds.), Diseases of Poultry, Ed. 6, pp. 470-502. Ames, IA: The Iowa State University Press, 1972.

35. Baba, T.W., and Humphries, E.H. Avian leukosis virus infection: analysis of viremia and DNA integration in susceptible and resistant chicken lines. J. Virol., 51: 123-130, 1984.

36. Baba, T., and Humphries, E.H. Formation of a transformed follicle is necessary but not sufficient for development of an avian leukosis virus-induced lymphoma. Proc. Natl. Acad. Sci. USA, 82: 213-216, 1985.

37. Neiman, P., Payne, L.N., and Weiss, R.A. Viral DNA in bursal lymphomas induced by avian leukosis viruses. J. Virol., 34: 178-186, 1980.

38. Gardner, M.B. Type C viruses and wild mice: characterization and natural history of amphotropic, ecotropic, and xenotropic MuLV. Curr. Top. Microbiol. Immunol., 79: 215-259, 1978.

39. Gardner, M.B., Rasheed, S., Estes, J.D., Casagrande, J., Ihle, J.N., and Stephenson, J.R. The history of viruses and cancer in wild mice. Cold Spring Harbor Conf. Cell Proliferation, 7: 971-987, 1980.

40. Lilly, F., Duran-Reynals, M.L., and Rowe, W.P. Correlation of early murine leukemia virus titer and H-2 type of spontaneous leukemia in mice of the BALB X AKR cross: a genetic analysis. J. Exp. Med., 141: 882-889, 1975.

41. Melamedoff, M., Lilly, F., and Duran-Reynals, M.L. Suppression of endogenous murine leukemia virus by maternal resistance factors. J. Exp. Med., 158: 506-514, 1983.

42. Lee, J.C., and Ihle, J.N. Chronic immune stimulation is required for Moloney leukemia virus-induced lymphomas. Nature (Lond.), 289: 407-409, 1981.

43. Pluznik, D.H., and Sachs, L. Quantitation of a murine leukemia virus with a spleen colony assay. J. Natl. Cancer Inst., 33: 535-546, 1964.

44. Duesberg, P.H., and Robinson, W.S. Nucleic acid and proteins isolated from the Rauscher mouse leukemia virus (MLV). Proc. Natl. Acad. Sci. USA, 55: 219-227, 1966.

45. Klement, V., and Nicolson, M.O. Methods for assays of RNA tumor viruses. Methods Virol., 6: 60-108, 1977.

46. Ihle, J.N., and Lee, I.C. Possible immunological mechanisms in C-type viral leukemogenesis in mice. Curr. Top. Microbiol. Immunol., 98: 85-100, 1981.

47. Mosier, D.E., Yetter, R.A., and Morse, H.C. Retrovirus induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161: 766-784, 1985.

48. Rowe, W.P., and Pincus, T. Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice. J. Exp. Med., 135: 429-436, 1972.

49. Crittenden, L.B. New hypotheses for viral unduction of lymphoid leukosis in chickens. Cold Spring Harbor Conf. Cell Proliferation, 7: 529-541, 1980.

50. Robinson, H.L., and Gagnon, G.C. Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas. J. Virol., 57: 28-36, 1986.

51. Little, C.C., per staff of Roscoe B. Jackson Memorial Laboratory. The existence of non-chromosomal influence in the incidence of mammary tumors in mice. Science (Wash. DC), 78: 465-466, 1933.

52. Bittner, J.J. The milk-influence of breast tumors in mice. Science (Wash. DC), 95: 462-463, 1942.

53. Cohen, J.C., and Varmus, H.E. Endogenous mammary tumor virus DNA varies among wild mice and segregates during inbreeding. Nature (Lond.), 278: 418-423, 1979.

54. Cardiff, R.D., and Young, L.J.T. Mouse mammary tumor biology: a new synthesis. Cold Spring Harbor Conf. Cell Proliferation, 7: 1105-1114, 1980.

55. Bentvelzen, P., Brinkhof, J., and Westenbrink, F. Expression of endogenous mammary tumor virus in mice: its genetic control and relevance to spontaneous mammary carcinogenesis. Cold Spring Harbor Conf. Cell Proliferation, 7: 1095-1104, 1980.

56. Cardiff, R.D., Morris, D.W., Young, L.J.T., and Strange, R. MuMTV genotype, proto-neoplasia, and tumor progression. In: M.A. Rich, J.C. Hager, and J. Taylor-Papadimitriou (eds.), Breast Cancer Origins, Detection and Treatment. Proceedings of the International Breast Cancer Research Conference, London, March 24-28, pp. 156-166. The Hague: Martinus Nijhoff Publishing, 1985.

57. Pathak, V.K., Strange, R., Young, L.J.T., Morris, D.W., and Cardiff, R.D. A survey of Int Region DNA rearrangements in C3H and BALB/cfC3H mouse mammary tumor systems. J. Natl. Cancer Inst., in press, 1987.

58. Altrock, B.W., and Cardiff, R.D. Mouse mammary tumor virus infection: virus expression and tumor risk potential. J. Nat'l. Cancer Inst., 63: 1075-1080, 1979.

59. Jarrett, W.F.H., Crawford, A.M., Martin, W.B., and Davie, F. Leukemia in the cat: a virus-like particle associated with leukemia (lymphosarcoma). Nature (Lond.), 202: 566-568, 1964.

60. Roberson, P., Jarrett, W., and Mackey, L. Epidemiological studies of feline leukemia virus infection I. A serological survey in urban cats. Int. J. Cancer, 15: 781-785, 1985.

61. Essex, M. Horizontally and vertically transmitted oncorna-viruses of cats. Adv. Cancer Res., 21: 175-248, 1975.

62. Dorn, C.R., Taylor, D.O.N., Schneider, R., Hibbard, H.H., and Klauber, M.R. Survey of animal neoplasms in Alameda and Contra Costa counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J. Nat'l. Cancer Inst., 40: 307-318, 1968.

63. Essex, M. Feline leukemia and sarcoma viruses. In: G. Klein (ed.), Viral Oncology, pp. 205-229, New York: Raven Press, 1960.

64. Jarrett, W.F., Jarrett, O., Mackey, L., Laird, W., Hardy, W.D., and Essex, M. Horizontal transmission of leukemia virus and leukemia in the cat. J. Nat'l. Cancer Inst., 51: 833-841, 1973.

65. Rojko, J.S., Hoover, E.A., Quackenbush, S.L., and Olsen, R.G. Reactivation of latent feline leukemia virus infection. Nature (Lond.), 298: 385-388, 1972.

66. Gutensohn, N., Essex, M., Francis, D.P., and Hardy, W.D. Risk of humans from exposure to feline leukemia virus: epidemiological considerations. Cold Spring Harbor Conf. Cell Proliferation, 7: 699-706, 1980.

67. Anderson, L.J., Jarrett, W.F.M., Jarrett, O., and Laird, H.M. Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J. Nat'l. Cancer Inst., 47: 807-817, 1971.

68. Hardy, W.D., Old, L.J., Hess, P.W., Essex, M., and Cotter, S. Horizontal transmission of feline leukemia virus. Nat. New Biol., 244: 266-269, 1973.

69. Kawatami, T.G., Sun, L., and McDowell, F.S. Infectious primate type-C virus shed by healthy gibbons. Nature (Lond.), 268: 448-450, 1977.

70. Kawatami, T.G., and McDowell, F.S. Factors regulating the onset of chronic myelogenous leukemia in gibbons. Cold Spring Harbor Conf. Cell Proliferation, 7: 719-727, 1980.

71. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D., and Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Porc. Nat'l. Acad. Sci. USA, 77: 7415-7419, 1980.

72. Miller, J.M., Miller, L.D., Olson, C., and Gillette, K.G. Virus-like particles in phytohemagglutinin stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J. Nat'l. Cancer Inst., 43: 1297-1305, 1969.

73. Miller, J.M., and van der Maaten, M.S. The biology of bovine leukemia virus infection in cattle. Cold Spring Harbor Conf. Cell Proliferation, 7: 901-999, 1980.

74. Mussgay, M., Dietzschold, R., Lorenz, R., Matheka, H.-D., Mattheus, W., Straub, O.C., Welland, F., Wilesmith, J.W., Frenzel, B., and Kaaden, O.R. Some properties of bovine leukemia virus, its use in seroepidemiological studies and eradication of the disease from infected herds. Cold Spring Harbor Conf. Cell Proliferation, 7: 911-925, 1980.

75. Kenyon, S.Y., Ferrer, J.F., McFeely, R.A., and Graves, D.C. Induction of lymphosarcoma in sheep by bovine leukemia virus. J. Nat'l. Cancer Inst., 67: 1157-1163, 1981.

76. Hoxie, J.E., Matthews, D.M., and Ames, D.B. Infection of human endothelial cells by human T-cell virus. Proc. Nat. Acad. Sci. USA, 81: 7591-7595, 1984.

77. Yoshikura, H., Nishida, J., Yoshida, M., Kitamura, Y., Takaku, F., and Ikeda, S. Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells. Int. J. Cancer, 33: 745-749, 1984.

78. Tajima, K., and Kuroishi, T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn. J. Clin. Oncol., 15: 423-430, 1985.

79. Maeda, Y., Furakawu, M., Takehara, Y., Yoshimura, Y., Miyumoto, K., Matsubara, T., Morishima, Y., Tajima, K., Okochi, K., and Hinuma, Y. Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study. Int. J. Cancer, 33: 717-730, 1984.

80. Pan, I.-H., Chung, C.-S., Komoda, H., Mai, J., and Hinuma, Y. Seroepidemiology of adult T-cell leukemia virus in Taiwan. Jpn. J. Cancer Res., 76: 9-11, 1985.

81. Okochi, K., Sato, H., and Hinuma, Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion of recipients. Vox Sang., 46: 245-253, 1984.

82. Kaplan, H.S. Mouse leukemia: interaction of multiple components in a complex oncogenic system. In: P. Emmelot and P. Bentvelzen (eds.), RNA Viruses and Host Genome in Onco-genesis, pp. 143-154. New York: North Holland, American Elsevier, 1972.

83. Fenner, F., and White, D.O. Medical Virology. New York: Academic Press, 1970.

84. Carter, J.K., Procter, F.J., and Smith, R.E. Induction of angiosarcomas by ring-necked pheasant virus. Infect. Immun., 40: 310-319, 1983.

85. Carter, J.K., and Smith, R.E. Rapid induction of hyperthyroidism by an avian leukosis virus. Infect. Immun., 40: 795-805, 1983.

86. Smith, R.E., and Morgan, J.H. Identification of plaque isolates of an avian retrovirus causing rapid and slow onset osteopetrosis. Virology, 119: 488-499, 1982.

87. Morgan, J.H., and Smith, R.E. Rapid induction of osteopetrosis by subgroup E. recombinant viruses. Virology 129: 493-500, 1983.

88. Carter, J.K., Ow, C.L., and Smith, R.E. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect. Immun., 39: 410-422, 1983.

89. Smith, R.E., and Van Eldik, J. Characterization of the immune suppression accompanying virus-induced avian osteopetrosis. Infect. Immun., 22: 452-461, 1978.

90. Rojko, J.S., Hoover, E.A., Lawrence, E.M., Richard, G.O., and Schaller, J.P. Pathogenesis of Experimental Feline Leukemia Virus Infection. J. Nat'l. Cancer Inst., 63: 759-765, 1979.

91. Fine, D.L., Landon, J.C., Pienta, R.J., Kubicek, M.T., Valerio, M.G., Leob, W.F., and Chopra, H.C. Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. J. Nat'l. Cancer Inst., 54: 651-658, 1975.

92. Marx, P.A., Maul, D.H., Osborn, K.G., Lerce, N.W., Moody, P., Lowenstine, L.J., Henrickson, R.V., Arthur, L.O., Gravell, M., London, W.T., Lever, J.L., Levy, J.A., Munn, P., and Gardner, M.B. Simian AIDS: isolation of a type D retrovirus and disease transmission. Science (Wash. DC), 223: 1083-1086, 1984.

93. Daniel, M.D., Letvin, N.L., King, N.W., Kannagi, M., Sehgal, P.K., Hunt, R.D., Kanki, P.J., Essex, M., and Desrosiers, R.C. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (Wash. DC), 228: 1201-1204, 1985.

94. Breindel, M., Harbers, K., and Jaenisch, R. Retrovirus-induced lethal mutation in collagen I gene of mice is associated with an altered chromatin structure. Cell, 38: 9-16, 1984.

95. King, W., Patel, M.D., Lobel, L.I., Goff, S.P., and Nguyen-Huu, M.C. Insertion mutagenesis of embryonal carcinoma cells by retroviruses. Science (Wash. DC), 228: 554-558, 1985.

96. Purchase, H.G., Ludford, C., Nazerian, K., and Cox, H.W. A new group of oncogenic viruses: reticuloendotheliosis, chick syncytial, chick infectious anemia, and spleen necrosis virus. J. Nat'l. Cancer Inst., 51: 489-499, 1973.

97. Keshet, E., and Temin, H.M. Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J. Virol., 31: 376-388, 1979.

98. Graf, T. A plaque assay for avian RNA tumor viruses. Virology, 50: 567-578, 1972.

99. Klement, V., Rowe, W.P., Hartley, J.W., and Pugh, W.E. Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture. Proc. Nat'l. Acad. Sci. USA, 63: 753-758, 1969.

100. Hartley, J.W., Wolford, N.K., Old, L.J., and Rowe, W.P. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Nat'l. Acad. Sci. USA, 74:

789-792, 1977.

101. Rangan, S.R.S., Ueberhorst, P.J., and Wong, M.C. Syncytial giant cell focus assay for viruses derived from feline leukemia and a simian sarcoma. Proc. Soc. Exp. Biol. Med., 142: 1077-1082, 1973.

102. Rangan, S.R.S., Wong, M.C., Ueberhorst, P.J., and Ablashi, D.J. Mixed culture cytopathogenecity induced by virus preparations derived from simian sarcoma virus (SSV-1) infected cultures. J. Nat'l. Cancer Inst., 49: 571-577, 1972.

103. Rand, K.H., Long, C.W., Wei, T.T., and Gilden, R.V. Plaque assay for the Mason-Pfizer monkey virus. J. Nat'l. Cancer Inst., 53: 449-452, 1974.

104. Diglio, C.A., and Ferrer, J.P. Induction of syncytia by the bovine C-type leukemia virus. Cancer Res., 36: 1056-1057, 1976.

105. Nagy, K., Clapham, P., Cheingsong-Popov, R., and Weiss, R.A. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patient's sera. Int. J. Cancer, 32: 321-328, 1983.

106. Hoshino, H., Shinoyama, M., Miwa, M., and Sugimura, T. Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc. Nat'l. Acad. Sci. USA, 80: 7337-7341, 1983.

107. Baba, T.W., and Humphries, E.H. Differential response to avian leukosis virus infection exhibited by two chicken lines. Virology, 135: 181-188, 1985.

108. Rich, M.A. Virus-induced murine leukemia. In: M.A. Rich (ed.), Experimental Leukemia, pp. 15-49. New York: Appleton-Century-Crofts, 1968.

109. Bentvelzen, P. The putative mam gene of the murine mammary tumor virus. In: G. Klein (ed.), Advances in Viral Oncology, pp. 141-152. New York: Raven Press, 1982.

110. Hardy, W.D., McClelland, A.J., Zuckerman, E.E., Snyder, H.W., MacEwen, E.G., Francis, D.P., and Essex, M. Immunology and epidemiology of feline leukemia virus nonproducer lympho-sarcomas. Cold Spring Harbor Cancer Conf. Cell Proliferation, 7: 677-697, 1980.

111. Kinoshita, K., Hino, S., Amagasaki, T., Yamada, Y., Kamihira, E., Ichimura, M., Munehisa, T., and Hinuma, Y. Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults. Gann, 73: 684-685, 1982.

112. Kinoshita, K., Amagasaki, T., Yamada, Y., Kamihira, E., Ichimura, M., Kamihira, S., Yamada, Y., Momita, S., Kusano, M., Morikawa, T., Fujita, S., Ueda, Y., Ito, N., and Yoshida, M. Preleukemic state of adult T cell leukemia: abnormal T lympho-cytosis induced by human adult T cell leukemia-lymphoma virus. Blood, 66: 120-127, 1985.

113. Gallo, R.C., Wong-Staal, F., Markham, P.D., Ruscetti, F., Kalyanaraman, V.S., Ceccherini-Nelli, L., Dalla Favera, R., Josephs, S., Miller, N.R., and Reitz, M.S. Recent studies with infectious primate retroviruses: hybridization to primate DNA and some biological effects on fresh human blood leukocytes by simian sarcoma virus and gibbon ape leukemia virus. Cold Spring Harbor Conf. Cell Proliferation, 7: 753-773, 1980.

114. Miyoshi, I., Yoshimoto, S., Kubonishi, I., Taguchi, H., Shiraishi, Y., Oktsuki, Y., and Akagi, T. Transformation of normal human cord lymphocytes by co-cultivation with a lethally irradiated human T-cell line carrying type C virus particles. Gann, 72: 997-998, 1981.

115. DeRossi, A., Aldovini, A., Franchini, G., Mann, D., Gallo, R.C., and Wong-Staal, F. Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphovirus type I: parameters of virus integration and expression. Virology, 143: 640-645, 1985.

116. Nowell, P.C., Finan, J.B., Clark, J.W., Sarin, P.S., and Gallo, R.C. Karyotypic differences between primary cultures and cell lines from tumors with the human T-cell leukemia virus. J. Nat'l. Cancer Inst., 73: 849-852, 1984.

117. Crittenden, L.B. Two levels of genetic resistance to lymphoid leukosis. Avian Dis., 19: 281-292, 1975.

118. Fung, Y.-K.T., Fadly, A.M., Crittenden, L.B., and Kung, H.-J. Avian lymphoid leukosis virus infection and DNA integration in the preleukotic bursal tissues: a comparative study of susceptible and resistant lines. Virology, 119: 411-421, 1982.

119. Raines, M.A., Lewis, W.G., Crittenden, L.B., and Kung, H.-J. c-erb B activation in avian leukosis virus-induced erythroblastosis: clustered integration sites and the arrangement of provirus in the c-erb B alleles. Proc. Nat'l. Acad. Sci. USA, 82: 2287-2291, 1985.

120. Robinson, H.L., Miles, B.D., Catalano, D.E., Broles, W.E., and Crittenden, L.B. Susceptibility to erb B-induced erythroblastosis is a dominant trait of 15I chickens. J. Virol., 55: 617-622, 1985.

121. Crittenden, L.B., Witter, R.L., Okazaki, W., and Neiman, P.E. Lymphoid neoplasms in chicken flocks free of infection with exogenous avian tumor viruses. J. Nat'l. Cancer Inst., 63: 191-200, 1979.

122. Miles, B.D., and Robinson, H.L. High-frequency transduction of c-erb B in avian leukosis virus-induced erythroblastosis. J. Virol., 54: 295-303, 1985.

123. Purchase, H.G., Gilmour, P.G., Romero, C.H., and Okazaki, W. Post-infection genetic resistance to avian lymphoid leukosis resides in B target cells. Nature (Lond.), 270: 61-62, 1977.

124. Bacon, L.D., Witter, R.L., Crittenden, L.B., Fadly, A., and Motta, J. B-haplotype influence on Marek's disease, Rous sarcoma, and lymphoid leukosis virus-induced tumors in chickens. Poult. Sci., 60: 1132-1139, 1981.

125. Meruelo, D., Nimelstein, S.H., Jones, P.P., Lieberman, M., and McDevitt, H.O. Increased synthesis and expression of H-2 antigens on thymocytes as a result of leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia. J. Exp. Med., 147: 470-487, 1978.

126. Evans, L.H., Duesberg, P.H., and Scolnick, E.M. Replication of spleen focus-forming Friend virus in fibroblasts form C57BL mice that are genetically resistant to spleen focus formation. Virology, 101: 534-539, 1980.

127. Dux, A. Genetic aspects in the genesis of mammary cancer. In: P. Heston, W.E. Genetic factors in tumorigenesis. In: P. Emmelot and P. Bentvelzen (eds.), RNA Viruses and Host Genome in Oncogenesis, pp. 301-308. New York: American Elsevier, 1972.

128. Heston, W.E. Genetic factors in tumorigenesis. In: P. Emmelot and P. Bentvelzen (eds.), RNA Viruses and Host Genome in Oncogenesis, pp. 13-24. New York: American Elsevier, 1972.

129. Moore, D.H., Long, C.A., Vaidya, A.B., Sheffield, J.B., Dion, A.G., and Lasfargues, E.Y. Mammary tumor viruses. Adv. Cancer Res., 29: 347-418, 1979.

130. Hayward, W.S., Neel, B.G., and Astrin, S.M. Activation of a cellular onc gene by promoter insertions in ALV-induced lymphoid leukosis. Nature (Lond.), 290: 475-480, 1981.

131. Neel, G.B., Hayward, W.S., Robinson, H.L., Fong, J., and Astrin, S.M. Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell, 23: 323-324, 1981.

132. Payne, G.S., Bishop, J.M., and Varmus, H.E. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphoma. Nature (Lond.), 295: 209-214, 1982.

133. Astrin, S.M., Robinson, H.L., Crittenden, L.B., Buss, E.G., Wyban, J., and Hayward, W.S. Ten genetic loci in the chicken that contain structural genes for endogenous avian leukosis virus. Cold Spring Harbor Symp. Quant. Biol., 44: 1105-1109, 1980.

134. Weiss, R.A., and Frisby, D.P. Are avian endogenous viruses pathogenic? In: D.J. Yohn and J.R. Blakeslee (eds.), Advances in Comparative Leukemia Research 1981, pp. 303-311. Amsterdam: Elsevier/North-Holland Biomedical Press, Inc., 1982.

135. Horak, I., Lee, J.C., Enjuanes, L., and Ihle, J.N. Characterization of a unique defective type C-virus associated with a Moloney leukemia virus-induced splenic T-cell lymphoma cell line. J. Virol., 30: 299-308, 1980.

136. Corcoran, L.M., Adams, J.M., Dunn, A.R., and Cong. S. Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell, 37: 113-122, 1984.

137. Tsichlis, P.N., Strauss, P.G., and Kozak, C.A. Cellular DNA region involved in induction of thymic lymphomas (Mlvi-2) maps to mouse chromosome 15. Mol. Cell Biol., 4: 997-1000, 1984.

138. McGrath, C.M., Nandi, S., and Young, L.J.T. Relationship between organization of mammary tumor and the ability of tumor cells to replicate mammary tumor virus and to recognize growth-inhibitory contact signals in vitro. J. Virol., 9: 367-376, 1972.

139. Bentvelzen, P. Hereditary infections with mammary tumor viruses in mice. In: P. Emmelot and P. Bentvelzen (eds.), RNA Viruses and Host Genome in Oncogenesis, pp. 309-337. New York: American Elsevier, 1972.

140. Peters, G., Brookes, S., Smith, R., and Dickson, C. Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell, 33: 369-377, 1983.

141. Gardner, M.B., Malone, R.W., Morris, D.W., Young, L.J.T., Strange, R., Cardiff, R.D., Foulkin, L.J., and Mitchell, D.J. Mammary tumors in feral mice lacking MuMTV DNA. J. Exp. Pathol., 2: 93-98, 1985.

142. Michalides, R., Van Deemter, L., Nusse, R., and Hegeman, P.C. Induction of mouse mammary tumor virus RNA in mammary tumors of BALB/c mice treated with urethane, X-irradiation and hormones. J. Virol., 31: 63-72, 1979.

143. Levy, L.S., Gardner, M.B., and Casey, J.W. Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma. Nature (Lond.), 308: 853-856, 1984.

144. Mullins, J.L., Brody, D.S., Binasi, R.C., and Cotten, S.M. Viral transduction of c-myc in naturally occurring feline leukemias. Nature (Lond.), 308: 856-858, 1984.

145. Neil, J.C., Hughes, D., McFarlane, R., Wilkie, N.M., Onions, D.E., Lees, G., and Jarrett, O. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (Lond.), 308: 814-820, 1984.

146. Kettmann, R., Deschamps, J., Clerter, Y., Couez, D., Burny, A., and Marbaix, G. Leukemogenesis by bovine leukemia virus: Proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc. Nat'l. Acad. Sci. USA, 79: 2465-2469, 1982.

147. Rosen, C.A., Sodroski, J.G., Kettmann, R., Burny, A., and Hazeltine, W.A. trans activation of the bovine leukemia virus long terminal repeat in BVL-infected cells. Science (Wash. DC), 227: 320-322, 1985.

148. Kettmann, R., Deschamps, J., Couez, D., Claustriaux, J.J., Palm, R., and Burny, A. Chromosome integration domain for bovine leukemia provirus in tumors. J. Virol., 47: 146-150, 1983.

149. Hoshino, H., Esumi, H., Miwa, M., Shimoyama, M., Minato, K., Tobinai, K., Hirose, M., Natunabe, S., Inadu, N., Konishita, K., Komihira, S., Ichimara, M., and Sugimara, T. Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc. Nat'l. Acad. Sci. USA, 80: 6061-6065, 1983.

150. Franchini, G., Wong-Staal, F., and Gallo, R.C. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc. Nat'l. Acad. Sci. USA, 81: 6207-6211, 1984.

151. Wong-Staal, F., Franchini, G., Hahn, B., Arya, S., Gelmann, E.P., Manzari, V., and Gallo, R.C. Human T-cell leukemia/lymphoma virus, in vitro transformation, and leukemia: some molecular studies. In: R.C. Gallo, M. Essex, and L. Gross (eds.), Human T-cell Leukemia-Lymphoma, pp. 133-139. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1984.

152. Sodroski, J.G., Rosen, C.A., and Haseltine, W.A. trans-Acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science (Wash. DC), 225: 381-385, 1984.

153. Burny, A. More and better transactivation. Nature (Lond.), 321: 378, 1986.

154. Yoshida, M., Seiki, M., Hattori, S., and Watanabe, F. Genome structure of human T-cell leukemia virus and its involvement in the development of adult T-cell leukemia/lymphoma. In: R.C. Gallo, M. Essex, and L. Gross (eds.), Human T-cell Leukemia-Lymphoma Virus, pp. 141-149. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1984.

155. Yoshida, M., Seiki, M., Yamaguchi, Y., and Takatsuki, K. Monoclonal integration of HTLV in all primary tumors of adult T-cell leukemias suggests causative role of HTLV in the disease. Proc. Nat'l. Acad. Sci. USA, 81: 2534-2537, 1984.

156. Takenaka, T., Nakamine, H., Oshiro, I., Maeda, J., Kobori, M., Hayashi, T., Komoda, H., Hinuma, Y., and Hanaoka, M. Serologic and epidemiologic studies on adult T-cell leukemia (ATL): special reference to a comparison between patients with and without antibody to ATL-associated antigen. Jpn. J. Clin. Oncol., 13(Suppl. 2): 257-268, 1983.

157. Tobinai, K., Nagai, M., Setoya, T., Shibata, T., Minato, K., and Shimoyama, M. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies. Jpn. J. Clin. Oncol., 13(Suppl. 2): 237-244, 1983.

158. Shimoyama, M., Kagami, Y., Shimotohno, K., Miwa, M., Minato, K., Tobinai, K., Suemasu, K., and Sugimura, T. Adult T-cell leukemia/lymphoma not associated with human T-cell leukemia virus type I. Proc. Nat'l. Acad. Sci. USA, 83: 4524-4528, 1986.

159. Manzari, V., Gradilone, A. Basillari, G., Fani, M., Collalti, E., Pandolfi, F., DeRossi, G., Liso, V., Babbo, P., Robert-Guroff, M., and Frati, L. HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population. Int. J. Cancer, 36: 557-559, 1985.

160. Pandolfi, F., De Rossi, G., Lauria, F., Ranucci, A., Barillari, G., Manzari, V., Semenzato, G., Liso, V., Pizzolo, G., and Aiuti, F. T-helper phenotype chronic lymphocytic leukeamia and "adult T-cell leukemia" in Italy. Lancet, 2: 633-636, 1985.

161. Nagy, K., Gyuris, A., Drexler, E., Foldes, I., Fust, G., and Horvath, A. Human T-lymphotropic virus infections in Hungary. In: Proceedings of the 14th International Cancer Congress Budapest, August 21-27, Abstract 1861, 1986.

162. Bishop, J.M. Enemies within the genesis of retrovirus oncogenes. Cell, 23: 5-6, 1981.

163. Steffen, D., and Weinberg, R.A. The integrated genome of murine leukemia virus. Cell, 15: 1003-1010, 1978.

164. Canaani, E., and Aaronson, S.A. Restriction enzyme analysis of mouse cellular type C viral DNA: emergence of new viral sequences in spontaneous AKR lymphomas. Proc. Nat'l. Acad. Sci. USA, 76: 1677-1687, 1979.

165. Seiki, M., Eddy, R., Shows, T.B., and Yoshida, M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells. Nature (Lond.), 309: 640-642, 1984.

166. Hann, S.R., Abrams, H., Rohrschneider, L., and Eisenman, R. Proteins encoded by v-myc and c-myc oncogenes: identification and localization in acute leukemia virus transformants and bursal lymphoma cell lines. Cell, 34: 789-798, 1983.

167. Shih, C.-K., Linial, M., Goodenow, M.M., and Hayward, W.S. Nucleotide sequence 5' of the chicken c-myc coding region: localization of a non-coding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas. Proc. Nat'l. Acad. Sci. USA, 81: 4697-4701, 1984.

168. Pachel, C., Schubach, W., Eisenman, R., and Linial, M. Expression of c-myc RNA in bursal lymphoma cell lines: identification of c-myc encoded proteins by hybrid-selected translation. Cell, 33: 335-344, 1983.

169. Schubach, W., and Groudine, M. Alteration of c-myc chromatin structure by avian leukosis virus integration. Nature (Lond.), 307: 702-708, 1984.

170. Li, Y., Holland, C., Hartley, J., and Hopkins, N. Viral integration near c-myc in 10-20% of MCF247-induced AKR lymphomas. Proc. Nat'l. Acad. Sci. USA, 81: 6808-6811, 1984.

171. Steffen, D. Proviruses are adjacent to c-myc in some murine leukemia virus-induced lymphomas. Proc. Nat'l. Acad. Sci. USA, 81: 2097-2101, 1984.

172. O'Donnel, P.V., Fleissner, E., Lonial, H., Koehne, C.F., and Reicin, A. Early clonality and high-frequency proviral integration into the c-myc locus in AKR leukemias. J. Virol., 44: 500-503, 1985.

173. Nusse, R., and Varmus, H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31: 91-109, 1982.

174. Peters, G., Kozak, C., and Dickson, C. Mouse mammary tumor virus integration regions int-1 and int-2 map on different mouse chromosomes. Mol. Cell Biol., 4: 375-378, 1984.

175. Cooper, G.M., and Neiman, P.E. Two distinct candidate transforming genes of lymphoid leukosis virus-induced neoplasms. Nature (Lond.), 292: 857-858, 1981.

176. Sprent, J. Migration and lifespan of lymphocytes. In: F. Loor and G.E. Roelants (eds.), Band I cells in immune recognition, pp. 59-82. New York: John Wiley Sons, 1977.

177. Hayward, W.S. Multiple mechanisms of oncogene activation in viral and nonviral neoplasia. In: I.L. Weissman (ed.), Leukemia, Dahlem Konferenzen Berlin, pp. 147-162. Berlin: Springer-Verlag, 1985.

178. Dofuku, R., Biedler, J.L., Spengler, B.A., and Old, L.J. Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. Proc. Nat'l. Acad. Sci. USA, 72: 1515-1517, 1975.

179. Wiener, F., Ohno, S., Spira, J., Haran-Ghera, N., and Klein, G. Chromosome changes (trisomies, no. 15 and 17) associated with tumor progression in leukemias induced by radiation leukemia virus. J. Nat'l. Cancer Inst., 61: 227-237, 1978.

180. Spira, J., Wiener, F., Ohno, S., and Klein, G. Is MLV or DMBA trisomy cause or consequence of murine T-cell leukemia development? Studies on Robertsonian translocation in mice. Proc. Nat'l. Acad. Sci. USA, 76: 6619-6621, 1979.

181. Dofuku, R., Utakoij, T., and Matsuzawa, A. Trisomy of chromosome 13 in spontaneous mammary tumors of GR, C3H and non-inbred Swiss mice. J. Nat'l. Cancer Inst., 63: 651-656, 1979.

182. Hare, W.C.C., Yang, T.-J., and McFreely, R.A. A survey of chromosome findings in 47 cases of bovine lymphosarcoma (leukemia). J. Nat'l. Cancer Inst., 38: 383-392, 1967.

183. Sadamori, N., Kusano, M., Nishimo, K., Fagawa, M., Yao, E., Yamada, Y., Amagasaki, T., Kinoshita, K., and Ichimara, M. Abnormalities of chromosome 14 at band 14g11 in Japanese patients with adult T-cell leukemia. Cancer Genet. Cytogenet., 17: 279-282, 1985.

184. Rowley, J.D., Haven, J.M., Wong-Staal, F., Franchini, G., Gallo, R., and Blattner, W. Chromosome pattern in cells from patients positive for human T-cell leukemia/lymphoma virus. In: R.C. Gallo, M. Essex, and L. Gross (eds.), Human T-cell Leukemia/Lymphoma Virus, pp. 85-89. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1984.

185. Sanada, I., Tanaka, R., Kumagai, E., Tsuda, H., Nishimura, H., Yamaguchi, K., Kawano, F., Fujiwara, H., and Takatsuki, K. Chromosomal aberrations in adult T cell leukemia: relationship to the clinical severity. Blood 65: 649-654, 1985.

186. Pandolfi, F. T-CLL and allied diseases: new insights into classification and pathogenesis. Dign. Immunol., 4: 61-74, 1986.

187. Pandolfi, F., De Rossi, G., and Semenzato, G. T-helper phenotype leukemias: role of HTLV-I. Lancet, 2: 1367-1368, 1985.

188. Fialkow, P.J., and Singer, J.W. Tracing development and cell lineages in human hemopoietic neoplasia. In: I.L. Weissman (ed.), Leukemia, Dahlem Konferenzen Berlin, pp. 203-222. Berlin: Springer-Verlag, 1985.

189. Ueshima, Y., Rowley, J.D., Variakojis, D., Winter, J., and Gordon, L. C

198. Haran-Ghera, N. Pathogenesis of murine leukemia. In: G. Klein (ed.), Viral Oncology, pp. 161-185. New York: Raven Press, 1980.

199. Chang, T.D., Biedler, J.L., Stockert, E., and Old, L.J. Trisomy of chromosome 15 in X-ray-induced mouse leukemia. Proc. Soc. Am. Assoc. Cancer Res., 18: 225, 1977.

200. Klein, G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc. Nat'l. Acad. Sci. USA, 76: 2442-2446, 1979.

201. Spira, J., Babowits, M., Wiener, F., Ohno, S., Wirschubski, Z., Haran-Ghera, N., and Klein, G. Non-random chromosomal changes in Thy-1-positive and Thy-1 negative lymphomas induced by 7, 12-dimethylbenzanthracene in S26 mice. Cancer Res., 40: 2609-2616, 1980.

202. Erikson, J., Williams, D.L., Finan, J., Howell, P.C., and Croce, C. Locus of the (a)-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias. Science (Wash. DC), 229: 784-786, 1985.

203. Hecht, F., Morgan, R., Kaiser-McCaw-Hecht, B., and Smith, S. Common region on chromosome 14 in T-cell leukemia and lymphoma. Science (Wash. DC), 226: 1445-1447, 1984.

204. Chen, I.S.Y., Slamon, D.J., Rosenblatt, J.D., Shah, N.P., Quan, S.G., and Wachsman, W. The x gene is essential for HTLV replication. Science (Wash. DC), 229: 54-58, 1985.

205. Haas, M., Mally, M.I., Bogenberger, J.M., Bogart, M.H., Buchannan, M.A., Augery-Bourget, Y., Hyman, R., and Vogt, M. Autocrine growth and progression of murine X-ray-induced T cell lymphomas. EMBO J., 5: 1775-1782, 1986.

206. Oliff, A., McKinney, M.D., and Agranovsky, O. Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus. J. Virol., 54: 864-868, 1985.

207. Gazzolo, L., Moscovici, C., and Moscovici, M.G. Persistence of avian oncoviruses in chicken macrophages. Infect. Immun., 23: 294-297, 1979.

208. Schwarz, H., Ihle, J.N., Wecker, E., Fischinger, P.O., Thiel, H.-J., Bolognesi, D.P., and Schafer, W. Properties of mouse leukemia viruses. XVI. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71. Virology, 111: 568-578, 1981.

209. Marx, J.L. AIDS virus has new name-perhaps. Science (Wash. DC), 232: 699-700, 1986.

210. Levy, J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A., Shimabukuro, J.M., and Oshiro, L.S. Isolation of lympho-cytopathic retroviruses from San Francisco patients with AIDS. Science (Wash. DC), 225: 840-842, 1984.

211. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palher, F.J., Redfield, R., Oleske, J., Safai, B., White, F., Foster, P., and Markham, P.D. Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science (Wash. DC), 224: 500-503, 1984.

212. Salahuddin, S.A., Markham, P.D., Popovic, M., Sarngadharan, M.G., Orndorff, S., Fladagar, A., Patel, A., Gold, J., and Gallo, R.C. Isolation of infectious T-cell leukemia/lymphoma virus type III (HTLV-III) from patients with acquired immuno-deficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc. Nat'l. Acad. Sci. USA, 82: 5530-5534, 1985.

213. Levy, J.A., Kaminsky, L.S., Morrow, M.J.W., Steiner, K., Luciw, P., Dina, D., Hoxie, J., and Oshiro, L. Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Ann. Intern. Med., 103: 694-699, 1985.

214. Levy, J.A., and Shimabukuro, J. Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. J. Infect. Dis., 152: 734-738, 1985.

215. Gottlieb, M.S., Schroff, R., Schamber, H.M., Weisman, J.D., Fan, P.T., Wolf, R.A., and Saxon, A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immuno-deficiency. N. Engl. J. Med., 305: 1425-1431, 1981.

216. Centers for Disease Control. Weekly surveillance report, October 20, 1986.

217. Sarngadharan, M.G., Popovic, M., Brach, L., Schupbach, J., and Gallo, R.C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (Wash. DC), 224: 506-508, 1984.

218. Blattner, W.A., Biggar, R.J., Weiss, S.H., Melbye, M., and Goedert, J.J. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Ann. Intern. Med., 103: 665-670, 1985.

219. Kaminsky, L.S., McHugh, T., Stites, D., Volberding, P., Henle, G., Henle, W., and Levy, J.A. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc. Nat'l. Acad. Sci. USA, 82: 5535-5539, 1985.

220. Peterman, T.A., Jaffe, H.W., Feorino, P.M., Haverkos, H.W., Stoweburner, R.L., and Curran, J.W. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA, 254: 2913-2917, 1985.

221. Clumeck, N., Robert-Guroff, M., Van De Perre, P., Jennings, A., Sibomana, J., Demol, P., Cran, S., and Gallo, R.C. Sero-epidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans. JAMA, 254: 2599-2602, 1985.

222. Gottlieb, M.S., Wolfe, P.R., Fahey, J.L., Knight, S., Hardy, D., Eppolito, L., Ashida, E., Patel, A., Beall, G.N., and Sun, N. The syndrome of persistent generalized lymphodenopathy: experience with 101 patients. Adv. Exp. Med. Biol., 187: 85-91, 1985.

223. Curran, J.W., Morgan, M.W., Hardy, A.M., Jaffe, H.W., Darrow, W.W., and Dowdle, W.R. The epidemiology of AIDS: current status and future prospects. Science (Wash. DC), 229: 1352-1357, 1985.

224. Sivak, S.L., and Wormser, G.P. How common is HTLV-III infection in the United States? N. Engl. J. Med., 313: 1352, 1985.

225. McDougal, J.S., Cort, S.P., Kennedy, M.S., Cabridilla, C.D., Feorino, P.M., Francis, D.P., Hicks, D., Kalyanaraman, V.S., and Martin, L.S. Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J. Immunol. Methods, 76: 171-183, 1985.

226. Robert-Guroff, M., Brown, M., and Gallo, R.C. HTLV-III neutralizing antibodies in patients with AIDS and ARC. Nature (Lond.), 316: 72-74, 1985.

227. Weiss, R.A., Clapham, P.R., Cheingsong-Popov, R., Dalgleish, A.G., Carne, C.A., Weller, I.V.D., and Tedder, R.S. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (Lond.), 316: 69-72, 1985.

228. Saxinger, C., Levine, P.H., Lange-Wantzin, G., and Gallo, R. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Cancer Res. (Suppl.), 45: 4624-4626, 1985.

229. Bayley, A.C., Cheingsong, Popov, R., Dalgleish, A.G., Downing, R.G., Tedder, R.S., and Weiss, R.A. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet, 1: 359-361, 1985.

230. Black, P.H. HTLV-III, AIDS, and the brain. N. Engl. J. Med., 313: 1538-1540, 1985.

231. Resnick, L., DiMarzo-Veronese, F., Schupbach, J., Tortellotte, W.W., Ho, D.D., Muller, F., Shapshak, P., Vogt, M., Gropman, J.E., Markham, P.D., and Gallo, R.C. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N. Engl. J. Med., 313: 1498-1510, 1985.

232. Ho, D.D., Rota, T.R., Schooley, R.T., Kaplan, J.C., Allan, J.D., Groopman, J.E., Resnick, L., Felsenstein, D., Andres, G.A., and Hirsch, M.S. Isolation of HTLV-III from cerebrospinal fluid and neural tissue of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med., 313: 1493-1497, 1985.

233. Goedert, J.J., Biggar, R.J., Weiss, S.H., Eyster, M.E., Melbye, M., Wilson, S., Ginzburg, H.M., Grossman, R.J., DiGiola, R.A., Sanchez, W.C., Giron, J.A., Ebbesen, P., Gallo, R.C., and Blattner, W.A. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (Wash. DC), 231: 992-995, 1986.

234. Biggar, R.J. The AIDS problem in Africa. Lancet, 1: 79-83, 1986.

235. Kreiss, J.K., Koech, D., Plummer, F.A., Holmes, K.K., Lightfoote, M., Piot, P., Ronald, A.R., Ndinya-Achola, J.O., D'Costa, L.J., Roberts, P., Ngugi, E.N., and Quinn, T.C. AIDS virus infection in Nairobi prostitutes-spread of the epidemic to East Africa. N. Engl. J. Med., 314: 414-417, 1986.

236. Rodriguez, L., Sinangil, F., Godoy, G., Dewhurst, S., Merino, F., and Volsky, D.J. Antibodies to HTLV-III/LAV among aboriginal Amazonian Indians in Venezuela. Lancet, 2: 1098-1100, 1985.

237. Levy, J.A., and Ziegler, J.L. Acquired immune deficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary stimulation. Lancet, 2: 78-81, 1983.

238. Hoxie, J.A., Haggarty, B.S., Rachowski, J.L., Pilsbury, N., and Levy, J.A. Persistent noncytopathic infection of human lymphocytes with AIDS-associated retrovirus. Science (Wash. DC), 229: 1400-1402, 1985.

239. Anonymous Report. Needle-stick transmission of HTLV-III from a patient infected in Africa. Lancet, 2: 1376-1377, 1984.

240. Cooper, D.A., Maclean, P., Finlayson, R., Michelmore, H.M., Gold, J., Donovan, B., Barnes, T.G., Brooke, P., and Penny, R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet, 1: 537-540, 1985.

241. Eyster, M.E., Goedert, J.J., Sarngadharan, M.G., Weiss, S.H., Gallo, R.C., and Blattner, W.A. Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA, 253: 2219-2223, 1985.

242. Feorino, P.M., Jaffe, H.W., Palmer, E., Peterman, T.A., Francis, D.E., Kalzunaran, V.S., Weinstein, R.A., Stoneburner, R.L., Alexander, W.J., Ruersky, C., Getchell, J.P., Weinfeld, D., Haverkos, H.W., Kilbourne, B.W., Nicholson, J.K.A., and Curran, J.W. Transfusion-asociated acquired immune deficiency syndrome. N. Engl. J. Med., 312: 1293-1296, 1985.

243. Sarin, P.S., and Gallo, R.C. The involvement of human T-lymphotropic viruses in T-cell leukemia and immune deficiency. Cancer Rev., 1: p. 1-17, Copenhagen: Einar Munksgaard, 1986.

244. Sande, M.A. Transmission of AIDS. The case against casual contagion. N. Engl. J. Med., 314: 380-382, 1986.

245. Dayton, A.I., Sodroski, J.G., Rosen, G.A., Goh, W.C., and Haseltine, W.A. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell, 44: 941-947, 1986.

246. Shaw, G.M., Hahn, B.H., Arya, S.K., Groopman, J.E., Gallo, R.C., and Wong-Staal, F. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (Wash. DC), 226: 1165-1167, 1984.

247. Harper, M.E., Marselle, L.M., Gallo, R.C., and Wong-Staal, F. Detection of lymphocytes expressing T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Nat'l. Acad. Sci. USA, 83: 772-776, 1986.

248. Folks, T., Powell, D.M., Lightfoote, M.M., Benn, S., Martin, M., and Fauci, A. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science (Wash. DC), 231: 600-602, 1986.

249. Centers for Disease Control. Update: acquired immuno-deficiency syndrome -- United States. Morbidity Mortality Weekly Rep., 34: 245-248, 1985.

250. Beard, J.W. Avian virus growth and their etiological agents. Adv. Cancer Res., 7: 1-127, 1963.

251. Fischinger, P.J., Ihle, J.N., Levy, J.-P., Bolognesi, D.P., Elder, J., and Schaefer, W. Recombinant murine leukemia viruses and protective factors in leukemogenesis. Cold Spring Harbor Conf. Cell Proliferation, 7: 989-1103, 1980.

252. Centers for Disease Control. Update: evaluation of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection in health care personnel-United States. Morbidity Mortality Weekly Rep., 34: 575-578, 1985.

253. Friedland, G.H., Satzman, B.R., Rogers, M.F., Kahl, P.A., Lesser, M.L., Mayers, M.M., and Klein, R.S. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N. Engl. J. Med., 314: 344-349, 1986.

254. Klatzmann, D., Barre-Sinoussi, F., Nugeyre, M.T., Dauguet, C., Vilmer, E., Griscelli, C., Brun-Vezinet, F., Rouzioux, C., Gluckman, J.C., Chermann, J.C., and Montagnier, L. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (Wash. DC), 225: 59-63, 1984.

255. Barnes, D.M. AIDS-related brain damage unexplained. Science (Wash. DC), 232: 1091-1093, 1986.

256. Lifson, G.D., Feinberg, M.B., Reyes, G.R., Rabin, L., Banapour, B., Chakrabarti, S., Moss, B., Wong-Staal, F., Steiner, K.S., and Engleman, E.G. Induction of CD4-dependent cell fusion by HTLV-III/LAV envelope glycoprotein. Nature (Lond.), 323: 725-728, 1986.

257. Gartner, S., Markovits, P., Markovitz, D., Kaplan, M., Gallo, R., Popovic, M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (Wash. DC), 233: 215-219, 1986.

258. Stewart, S.J., Fujimoto, J., and Levy, R. Human T lymphocytes and monocytes bear the same leu-3 (T4) antigen. J. Immunol., 136: 3773-3778, 1986.

259. Montagnier, L., Gruest, J., Chamaret, S., Dauguet, C., Axler, C., Guetard, D., Nugeyre, M.T., Barre-Sinoussi, F., Chermann, J.-C., Burnet, J.B., Klatzmann, D., and Gluckman, J.C. Adaptation of lymphodenopathy associated virus (LAV) to replication in EBT-transformed B lymphoblastoid cells lines. Science (Wash. DC), 225: 63-66, 1984.

260. Levy, J.A., Cheng-Mayer, C., Dina, D., and Luciw, P. AIDS retrovirus (ARV) replicates in human and animal fibroblasts transfected with a molecular clone. Science (Wash. DC), 232: 998-1011, 1986.

261. Shaw, G.M., Harper, M.E., Hahn, B.H., Epstein, L.G., Gajdusek, D.C., Price, R.W., Naria, B.A., Petito, C.K., O'Hara, C.J., Groopman, J.E., Cho, E.-S., Oleske, J.M., Wong-Staal, F., and Gallo, R.C. HTLV III infection in brains of children and adults with AIDS encephalopathy. Science (Wash. DC), 277: 177-181, 1985.

262. Daniel, M.D., King, N.W., Letvin, N.L., Hunt, R.D., Seghal, P.K., and Desrosiers, R.C. A new type D retrovirus isolated from macaques with immune-deficiency syndrome. Science (Wash. DC), 223: 602-605, 1984.

263. Letwin, N.L., Daniel, M.A., Seghal, P.K., Chaliloux, L.V., King, N.W., Hunt, R.D., Aldrich, W.R., Holley, K., Schmidt, D.K., and Desrosiersm, R.C. Experimental infection of rhesus monkeys with type D retrovirus. J. Virol., 52: 683-686, 1984.

264. Kanki, P.J., Alroy, J., and Essex, M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science (Wash. DC), 230: 951-954, 1985.

265. Fultz, P.N., McClure, H.M., Swenson, R.B., McGrath, C.R., Brodie, A., Getchell, J.P., Jensen, F.C., Anderson, D.C., Broderson, J.R., and Francis, D.P. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphodenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J. Virol., 58: 116-124, 1986.

266. Purtilo, D.T., Kipscomb, H., Krueger, G., Sonnabend, J., Casareale, D., and Volsky, D.J. Role of Epstein-Barr virus in acquired immune deficiency syndrome. Adv. Exp. Med. Biol., 187: 53-65, 1985.

267. Peutherer, J.F., Edmond, E., Simmonds, P., Dickson, J.D., and Bath, G.E. HTLV-III antibody in Edinburgh drug addicts. Lancet, 2: 1129-1130, 1985.

268. Koprowski, H., DeFreitas, E., Harper, M.E., Sandberg-Wollheim, M., Sheremata, W., Robert-Guroff, M., Saxinger, C.W., Feinberg, M.B., Wong-Staal, F., and Gallo, R.C. Multiple sclerosis and human T-cell lymphoytropic retroviruses. Nature, 318: 154-160, 1985.

269. Lairmore, M.D., Rosadio, R.H., and De Martini, J.C. Ovine lentivirus lymphoid interstitial pneumonia. Rapid induction in neonatal lambs. Am. J. Path., 125: 173-181, 1986.

270. Chen, I.Y., Wachsman, W., Rosenblatt, J.D., and Cann, A.J. The role of the X gene in HTLV associated malignancy. Cancer Surveys 5 (2): 331-342, 1986.

271. Gallo, R.C. The first human retrovirus. Scientific American, 255 (6): 88-98, 1986.

272. Zijlstra, M., and Melief, C.J.M. Virology, genetics and immunology of murine lymphomagenesis. Biochem. et. Biophys. Acta, 865: 197-231, 1986.

273. Duesberg, P.H. Cancer genes: rare recombinants instead of activated oncogenes. Proc. Nat'l. Acad. Sci. USA, in press, 1987.

274. Stoler, M.H., Eskin, T.A., Been, S., Angerer, R.C., and Angerer, L.M. Human T-cell lymphotropic virus type III infection of the central nervous system. J. Am. Med. Assoc., 256: 2360-2364, 1986.

275. Chayt, K.J., Harper, M.E., Marselle, L.M., Lewin, E.B., Rose, R.M., Oleske, J.M., Epstein, L.G., Wong-Staal, F., and Gallo, R.C. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. J. Am. Med. Assoc., 256: 2356-2371, 1986.

276. Scott, G.B., Fischl, M.A., Klimas, N., Fletcher, M.A., Dickinson, G.M., Levine, R.S., and Parks, W.P. Mothers of infants with the acquired immuno-deficiency syndrome. J. Am. Med. Assoc., 253: 363-366, 1985.

277. Gonda, M., Wong-Staal, F., Gallo, R., Clements, J., Narayan, O., and Gilden, R. Sequence homology and morphologic similarity of HTLV-III and visna virus: a pathogenic lentivirus. Science, 227: 173-177, 1985.

278. Walker, C.M., Moody, D.J., Stites, D.P., and Levy, J.A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science, 234: 1563-1566, 1986.

Top of Page